NEW
YORK, Jan. 17, 2025 /PRNewswire/ -- Baird
Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or
the "Company"), a leader in minimally invasive Microwave Ablation
(MWA) technology, was present in San
Francisco amid the 2025 J.P. Morgan Healthcare Conference,
one of the most prominent healthcare investment gatherings
globally.
Following its successful debut on Nasdaq in October 2024, Baird Medical connected with
healthcare investors and industry leaders during the week of the
conference, engaging in meaningful discussions on the company's
advancements in microwave ablation technology and its commitment to
improving patient outcomes.
"Being in San Francisco during
the J.P. Morgan Healthcare Conference provided a valuable
opportunity to engage with shareholders, innovators, and advisors
in the healthcare sector," said Haimei Wu, Chairwoman of Baird
Medical. "These discussions allowed us to share our vision for
growth and innovation in the years ahead."
Looking ahead, Baird Medical remains committed to leveraging the
insights and relationships gained from these interactions to drive
its 2025 strategic initiatives. The company will continue expanding
its U.S. footprint and collaborating with key opinion leaders
(KOLs) who share its mission of enhancing patient care through
cutting-edge medical technology.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave
ablation (MWA) technology, offering advanced treatment solutions
for conditions such as thyroid nodules, breast disease, uterine
fibroids, and liver cancer. A publicly traded company on NASDAQ,
Baird Medical is dedicated to enhancing patient care through
precision, efficiency, and safety in its innovative medical
devices. For more information, please visit
https://bairdmed.com/
Forward-Looking Statements
This press release
contains forward-looking statements within the meaning of the
United States Private Securities Litigation Reform Act of 1995.
Forward-looking statements are statements that are not historical
facts and generally relate to future events or Baird Medical's
future financial or operational performance. In some cases, you can
identify forward-looking statements by terminology such as "may,"
"might," "will," "should," "expect," "intend," "plan,"
"anticipate," "believe," "estimate," "predict," "potential,"
"continue," or the negative of these terms or other similar
expressions.
These forward-looking statements are subject to risks,
uncertainties, and assumptions that could cause actual results or
outcomes to differ materially from those expressed or implied.
These statements are based on estimates and assumptions that, while
considered reasonable by Baird Medical and its management, are
inherently uncertain. Risks and uncertainties may emerge over time,
and it is not possible to anticipate all potential factors that
could affect Baird Medical's business and financial
performance.
Factors that could cause actual results to differ materially
include, but are not limited to: (1) the risk that Baird Medical
may not achieve its expansion goals in the United States, China, or other markets; (2) changes in
economic, regulatory, or market conditions that impact Baird
Medical's operations; (3) the ability to realize anticipated
benefits from ongoing business initiatives or strategic
transactions; (4) regulatory developments and compliance with
applicable laws; (5) risks related to the development,
commercialization, and market acceptance of Baird Medical's
products; and (6) other risks and uncertainties detailed in Baird
Medical's filings with the SEC.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they
are made. Baird Medical undertakes no obligation to update or
revise forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law. All forward-looking statements in this press release are
qualified in their entirety by this cautionary statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medical-engages-with-healthcare-leaders-amid-2025-jp-morgan-healthcare-conference-302353999.html
SOURCE BDMD